A patient with seizures and a positive drug screen: Three wrongs don't make a right

Canadian Journal of Clinical Pharmacology

Volumn 10, Issue 2, 2003, Pages 63-66

  Kozer, Eran ^a,b   Verjee, Zul ^b   Emelianova, Svetlana ^b   Koren, Gideon ^b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; BUTYROPHENONE; CARBAMAZEPINE; CHLORAMBUCIL; CHLOROQUINE; CLONIDINE; CYCLOSPORIN; DIGOXIN; EPHEDRINE; ERGOTAMINE; FENFLURAMINE; ISONIAZID; LITHIUM; MEFENAMIC ACID; METHYLPHENIDATE; MEXILETINE; MONOAMINE OXIDASE INHIBITOR; OPIATE; PEMOLINE; PHENOTHIAZINE DERIVATIVE; PHENYLBUTAZONE; PHENYTOIN; SALICYLIC ACID; UNINDEXED DRUG;

ADOLESCENT; ARTICLE; CASE REPORT; COMPLEX PARTIAL SEIZURE; CROSS ALLERGY; DIAGNOSTIC ERROR; DISEASE COURSE; DRUG SCREENING; HUMAN; IMMUNOASSAY; MALE; SEIZURE; TOXICITY TESTING;

EID: 0042928471     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ng SK, Hauser WA, Brust JC, Susser M. Alcohol consumption and withdrawal in new-onset seizures. N Engl J Med 1988;319:666-73.
2. Fujiwara T, Watanabe M, Matsuda K, Senbongi M, Yagi K, Seino M. Complex partial status epilepticus provoked by ingestion of alcohol: A case report. Epilepsia 1991;32:650-6.
3. Heckmatt J, Shaikh AA, Swash M, Scott DF. Seizure induction by alcohol in patients with epilepsy experience in two hospital clinics. J R Soc Med 1990;83:6-9.
4. Sugarman JM, Rodgers GC, Paul RI. Utility of toxicology screening in a pediatric emergency department. Pediatr Emerg Care 1997;13:194-7.
5. Zaccara G, Muscas GC, Messori A. Clinical features, pathogenesis and management of drug-induced seizures. Drug Saf 1990;5:109-51.
6. Fisher J. Immunoassay drug screen results: Easy to get, hard to interpret. J Toxicol Clin Toxicol 1998;36:115-6.
7. Cox MN, Baum CR. Toxicology reviews: Immunoassay in detecting drugs of abuse. Pediatr Emerg Care 1998;14:372-5.
8. Colbert DL. Drug abuse screening with immunoassays: Unexpected cross-reactivities and other pitfalls. Br J Biomed Sci 1994;51:136-46.
9. Chattergoon DS, Verjee Z, Anderson M, et al. Carbamazepine interference with an immune assay for tricyclic antidepressants in plasma. J Toxicol Clin Toxicol 1998;36:109-13.
10. Igwemezie LN, Beatch GN, McErlane KM, Walker MJ. Mexiletine's antifibrillatory actions are limited by the occurrence of convulsions in conscious animals. Eur J Pharmacol 1992;210:271-7.
11. Nelson LS, Hoffman RS. Mexiletine overdose producing status epilepticus without cardiovascular abnormalities. J Toxicol Clin Toxicol 1994;32:731-6.
12. Frank SE, Snyder JT. Survival following severe overdose with mexiletene, nifedipine, and nitroglycerine. Am J Emerg Med 1991;9:43-6.
13. Friedrich MJ. Report documents causes of child death. JAMA 1999;24;282:1903-5.
14. Ellenhorn MJ, Schonwald S, Ordog G, Wasserberger J, eds. Ellenehorn's Medical Toxicology. 2nd edn. Baltimore: Williams and Wilkins, 1997:49.
15. Kozer E, Verjee Z, Koren G. Misdiagnosis of a mexiletine overdose because of a nonspecific result of urinary toxicologic screening. N Engl J Med 2000;343:1971-2. (Lett)